Physician profile
Gregory W Bryan
NPI 1528035888
$3,547.97
in general payments reported to CMS, 2019-2025
29 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $833 · 2020: $85.35 · 2021: $199 · 2022: $615 · 2023: $750 · 2024: $701 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331 · Travel and Lodging: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,331.08 |
| Travel and Lodging | $483.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $513.94 | 2020-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $483.89 | 2023 | |
| Melinta Therapeutics, LLC | $298.78 | 2019 | |
| Heron Therapeutics, INC. | $232.16 | 2022 | |
| Organogenesis INC. | $219.49 | 2020-2024 | Puraply Am, Puraply |
| Stryker Corporation | $179.39 | 2019-2024 | Prostep Mica |
| Zimmer Biomet Holdings, INC. | $174.02 | 2019 | |
| Convatec INC. | $173.32 | 2023-2025 | |
| Smith+Nephew, INC. | $172.95 | 2019-2025 | Grafix Pl, Regranex, Collagenase Santyl |
| Medtronic, INC. | $155.24 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Crossroads Extremity Systems, LLC | $135.15 | 2019 | |
| Horizon Therapeutics Plc | $113.54 | 2021-2023 | Krystexxa |
| Averitas Pharma INC. | $107.43 | 2025 | Qutenza |
| Wright Medical Technology, INC. | $85.84 | 2019 | |
| Triad Life Sciences INC. | $74.10 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $71.39 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $66.27 | 2022-2023 | Senza |
| Amgen INC. | $64.35 | 2024-2025 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $59.00 | 2021-2023 | Jublia |
| Glenmark Therapeutics INC. | $30.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.53 | 2022 | |
| Nabriva Therapeutics, Plc | $19.96 | 2022 | |
| Kci USA, INC. | $16.61 | 2019 | |
| Curonix LLC | $14.24 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biowound Solutions, INC. | $14.22 | 2025 | Bio-Connekt |
| Orthofix Medical, INC. | $13.92 | 2025 | Physio-Stim |
| Kerecis Limited | $13.69 | 2022 | |
| Trice Medical, INC. | $12.50 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.